Clinical Trial Update: Allogenic Stem Cell Transplantation for Children, Adolescents and Young Adults With Relapsed or Refractory AML [Phase 3]

View source ↗

Summary

Phase 3 trial assessing allogeneic stem cell transplantation for children and young adults with relapsed or refractory acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Hannover Medical School | Conditions: Acute Myeloid Leukemia (AML) | Phase 3 | Status: COMPLETED